Massachusetts Healthcare Journal
SEE OTHER BRANDS

Fresh health and wellness news from Massachusetts

Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on July 15, 2025

Enkrypt AI Releases Groundbreaking CBRN Red Teaming Study, Uncovering Major Safety Gaps in Frontier AI Models

Enkrypt AI Releases Groundbreaking CBRN Red Teaming Study, Uncovering Major Safety Gaps in Frontier AI Models

First-of-its-kind report reveals critical vulnerabilities in AI safety systems, posing global security concerns BOSTON, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- Enkrypt AI Releases Groundbreaking CBRN Red Teaming Study, Uncovering Major …

Revolutionary Social Connection App, HealthSteps™, Blends Wellness with Community and Conversation

Revolutionary Social Connection App, HealthSteps™, Blends Wellness with Community and Conversation

HealthSteps™ blends fitness tracking with social features—match, chat, share, and grow healthier together. Now faster, smarter, and more interactive. WOBURN, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- A new player in the digital health and …

  BostonSight Expand Clinical Trials Capabilities

BostonSight Expand Clinical Trials Capabilities

Discovering better and more innovative ways to deliver optometric and ophthalmic care that improves outcomes NEEDHAM, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- BostonSight® announced today that it has expanded its clinical trials …

Naviday Health Advances AI-Guided Menopause Care Through Mayo Clinic Platform_Accelerate Program

Naviday Health Advances AI-Guided Menopause Care Through Mayo Clinic Platform_Accelerate Program

Tackling Long-Neglected Menopause Gaps in Women’s Health BOSTON, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- Naviday Health, a digital health company designing intelligent care pathways for women, announced continued momentum in its …

Arizona Imaging Group Southwest Medical Imaging Achieves 89% Script Upload Success with ScriptAid by Cranberry Peak

Arizona Imaging Group Southwest Medical Imaging Achieves 89% Script Upload Success with ScriptAid by Cranberry Peak

Southwest Medical Imaging used Cranberry Peak’s ScriptAid SaaS to streamline script collection. 275+ staff onboarded in 2 weeks, 85% uploaded <5 min. CAMBRIDGE, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- Southwest Medical Imaging (SMIL), one …

airSlate SignNow Partners with LaborEdge to Optimize Hiring Document Workflows for Healthcare Staffing Agencies

airSlate SignNow Partners with LaborEdge to Optimize Hiring Document Workflows for Healthcare Staffing Agencies

BOSTON, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- airSlate, a global leader in document workflow automation, has partnered with LaborEdge to integrate its award-winning eSignature solution, SignNow, into Nexus, LaborEdge’s comprehensive …

Mobility City of Worcester Keeps Massachusetts Veterans on the Move with Mobility Equipment Repairs

Mobility City of Worcester Keeps Massachusetts Veterans on the Move with Mobility Equipment Repairs

Owner Avi Chandavarkar's chose to help disabled people in New England by offering a mobility equipment repairs, rentals and sales center WORCESTER, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- Mobility City of Worcester MA, part of the …

Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th

Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th

Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company …

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Gain Therapeutics Announces Proposed Public Offering

Gain Therapeutics Announces Proposed Public Offering

BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

ADR Ratio Change

ADR Ratio Change

July 15, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the …

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the …

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals

Combined Company to Trade on Nasdaq Under Ticker “IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) today announced the results of …

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LONDON …

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce …

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

CARLSBAD, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2025, before the market opens on Tuesday, July 29, 2025. John …

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2025. …

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States

Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced …

XLA Health Launches Modern Outsourcing Platform to Help Medical Practices Slash Administrative Overload

XLA Health Launches Modern Outsourcing Platform to Help Medical Practices Slash Administrative Overload

New York, NY, July 15, 2025 (GLOBE NEWSWIRE) -- XLA Health (www.xlahealth.com) officially rebrands its HIPAA-compliant outsourcing platform designed to relieve private‐practice physicians of the everyday administrative grind. By pairing college-educated, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions